Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "economics"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"610 - Medicine & health"
dewey-ones:"330 - Economics"
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
20
of
102
Search:
'"economics"'
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Clinical and
economic
review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...CADTH common drug review Clinical and
economic
review report for Vedolizumab (Entyvio SC)...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cobicistat /
economics
...
”
Read Now
3
Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Thiophenes /
economics
...
”
Read Now
4
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Omalizumab /
economics
...
”
Read Now
5
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Omalizumab /
economics
...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.
Published 2018
CADTH
Subjects:
“
...Antiviral Agents /
economics
...
”
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...
Published 2018
CADTH
Subjects:
“
...Immunologic Factors /
economics
...
”
Read Now
8
CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance, Pharmaceutical Services /
economics
...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Ivabradine /
economics
...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Ivabradine /
economics
...
”
Read Now
11
CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance, Pharmaceutical Services /
economics
...
”
Read Now
12
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal, Humanized /
economics
...
”
Read Now
13
Pharmacoeconomic review report: Tiotropium bromide monohydrate (Spiriva respimat) for inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tiotropium Bromide /
economics
...
”
Read Now
14
Pharmacoeconomic review report: Tiotropium bromide monohydrate (Spiriva respimat) for inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tiotropium Bromide /
economics
...
”
Read Now
15
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal, Humanized /
economics
...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance, Pharmaceutical Services /
economics
...
”
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance, Pharmaceutical Services /
economics
...
”
Read Now
18
Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses : an economic analysis and budget impact analysis
by
Membe, Stephen K.
Published 2011
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Plasma Substitutes /
economics
...
”
Read Now
19
Pharmacoeconomic review report: Safinamide (Onstryv) (Valeo Pharma Inc.) : indication: for add-on therapy to a regimen that includes levodopa for the treatment of the signs and sym...
Published 2020
CADTH
Subjects:
“
...Drug Therapy, Combination /
economics
...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
Subjects:
“
...Antiviral Agents /
economics
...
”
1
2
3
4
5
6
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 610 - Medicine & health
Clear Filter
Classification: 330 - Economics
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
140 - Specific philosophical schools
11
700 - The arts; fine & decorative arts
10
600 - Technology
2
100 - Philosophy & psychology
1
Language
English
102
Collection
National Center for Biotechnology Information
102
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
63
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
5
Argáez, Charlene
3
Ho, Chuong
3
Campbell, Kaitryn
2
more ...
Chao, Yi-Sheng
2
Ford, Caitlyn
2
Gray, Casey
2
Kanga, Ismat
2
Visintini, Sarah
2
Young, Calvin
2
Adcock, Lorna
1
Frey, Nina
1
Lachance, Chantelle
1
MacDougall, Danielle
1
Membe, Stephen K.
1
Spry, Carolyn
1
Thompson, Wade
1
Williams, D.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22610+-+Medicine+%26+health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22economics%22&type=AllFields
Send by Email
×
Loading...